SLC2A3 and colorectal cancer: Clinically, low METTL14 expression was found to correlate with poor prognosis in colorectal cancer, especially in p53 wild-type colorectal cancers, highlighting the relevance of the METTL14, miR-6769b-3p/SLC2A3 and miR-499a-3p/PGAM1 pathways.